Alzheimer's Disease Data Initiative
@AlzData
Dedicated to advancing scientific breakthroughs in the treatment of Alzheimer's disease and related dementias.
This month, the AD Data Initiative coalition will be heading to Toronto to attend the @alzassociation International Conference. Stay tuned for updates on when and where to find us at #AAIC25.
We’re excited for the second Cohort of the Gates Sr. AD Fellowship program to join us in Toronto! These exceptional researchers are revolutionizing #ADRD research with AI-driven approaches. Meet them at #AAIC25: Booth 630 on July 30, 10:30-11:00AM.
What sets GRIP apart? It's built by researchers, for researchers - designed to solve real-world challenges like multimodal data ingestion, metadata issues, and collaboration barriers. GRIP is rethinking data from the ground up. Read our press release here: grip-research.org/global-researc…
The brain is the most complex organ in the human body. You can protect your brain health by: 🏃♀️ Exercising 🥗 Eating a healthy diet 😴 Getting enough sleep More tips on Tuesday’s #WorldBrainDay from @WHO: who.int/health-topics/…
Nearly half of dementia cases could be prevented or delayed by tackling 14 risk factors starting in childhood, including two new risks—high cholesterol and vision loss, suggests report from the Lancet Commission on dementia. On #WorldBrainDay, explore the report ➡️…
The Alzheimer’s drug pipeline is more robust than ever, moving beyond amyloid, with 138 novel drugs in 182 clinical trials targeting new biology of aging pathways, including inflammation, tau proteins, vascular health and more. @Medscape @DrJeffCummings wb.md/4lJh62p
10 days to #AAIC25 🚀 The AD Data Initiative enables #ADRD research through secure data sharing & collaboration. Join us and our coalition partners at Booth 630 to see how we're making neurodegeneration research open & accessible!
Data sharing has revolutionized countless research fields—why not Alzheimer's? @niranjanbose explains how successful data sharing models in maternal health became the blueprint for #ADRD research.
This Alzheimer's and Brain Awareness Month, there are more reasons than ever to be optimistic about the future of #Alzheimer's research. Our Interim Executive Director @niranjanbose shares what else gives him hope as we work to accelerate new breakthroughs and #EndAlz.
The open access AD Workbench manuscript is published in @AlzheimersAssoc journal! First official academic paper about AD Workbench and its suite of tools built for the #ADRD research community, now citable for all research leveraging the platform. Read: bit.ly/ADWBAlzJournals
Congratulations to our interoperability partner @imi_epnd on the release of their first biomarker case study dataset on the #EPNDHub today! The ATN dataset includes data from 350 participants across 10 cohorts, offering valuable insights into AD, PD and LBD.
🌟 The ATN dataset is here! 🌟 EPND’s first biomarker case study spans 350 participants across #Alzheimers, #Parkisons and #dementia with Lewy bodies. The dataset is now accessible on the #EPNDHub. Read our press release to learn more ➡️ eurekalert.org/news-releases/… (1/3)
Congratulations to AD Data Initiative GTAC Member, Prof. Takeshi Iwatsubo, MD, PhD, who will receive the Lifetime Achievement Award in Alzheimer’s Disease Therapeutic Research at #CTAD2025. His groundbreaking work in neuroimaging & neuropathology continues to shape #ADRD research
At #ADPD2025, we asked our partners and colleagues to share their perspective on how data sharing and global research collaboration can accelerate research progress.
At #ADPD2025, we asked our partners and colleagues about the emerging opportunities in #ADRD research and the potential to accelerate research breakthroughs. Here’s what they had to say. What are your thoughts on emerging opportunities in ADRD research in the year ahead?